Characterizing the ligand-binding affinity toward SARS-CoV-2 Mpro via physics-and knowledge-based approaches

ST Ngo, TH Nguyen, NT Tung, VV Vu… - Physical Chemistry …, 2022 - pubs.rsc.org
Computational approaches, including physics-and knowledge-based methods, have
commonly been used to determine the ligand-binding affinity toward SARS-CoV-2 main …

Design, synthesis and evaluation the bioactivities of novel 1, 3-dimethyl-6-amino-1H-indazole derivatives as anticancer agents

VH Hoang, NTK Trang, TC Minh, TH Lan… - Bioorganic & Medicinal …, 2023 - Elsevier
Abstract Indoleamine 2, 3-dioxygenase (IDO1) is a heme-containing enzyme mainly
responsible for the metabolism of tryptophan to kynurenine. To date, the IDO1 inhibitors …

[HTML][HTML] IDO1 inhibitors are synergistic with CXCL10 agonists in inhibiting colon cancer growth

M Yang, M Cao, X Zhang, B Fu, Y Chen, Y Tan… - Biomedicine & …, 2024 - Elsevier
Abstract Indoleamine 2, 3-dioxygenase 1 (IDO1) is an immune checkpoint that degrades L-
tryptophan to kynurenine (Kyn) and enhance immunosuppression, which can be an …

Discovery of 1H-indazole-6-amine derivatives as anticancer agents: simple but effective

NX Hoang, VH Hoang, T Ngo, T Y. Vu… - Letters in Drug Design …, 2023 - benthamdirect.com
Background: Indazole is a promising structure present in various biological activity
compounds; in particular, many 6-aminoindazole-containing compounds demonstrated …

Design, synthesis and biological evaluation of novel quinazoline derivatives as immune checkpoint inhibitors

TTL Vo, VH Hoang, PTP Dung, NA Chi, VM Huy… - Bioorganic & Medicinal …, 2024 - Elsevier
In this work, we report 14 novel quinazoline derivatives as immune checkpoint inhibitors,
IDO1 and PD-L1. The antitumor screening of synthesized compounds on ovarian cancer …

Design, synthesis, and evaluation of indoleamin-2, 3-dioxygenase 1 inhibition activity of novel 5/6-amino indazole derivatives with amide template.

NX Hoang, TTL Vo, VH Hoang… - Pharmaceutical …, 2023 - search.ebscohost.com
Abstract Indoleamine 2, 3-dioxygenase 1 (IDO1) is an enzyme participating in tryptophan
metabolism that has been implicated in numerous cancers. In the present study, a series of …

Recent advances in the development of nitrogencontaining heterocyclic compounds as anticancer agents: a review

W Ettahiri, M Saber, Z Ouzrour, S Lahmidi… - Moroccan Journal of …, 2023 - revues.imist.ma
N-heterocyclic compounds are a natural and rich source of pharmacologically active
molecules displaying anti-cancer properties through various antiproliferative mechanisms …

[PDF][PDF] Pharmaceutical Sciences Asia

NX Hoang, TTL Vo, VH Hoang, TK Nguyen, JH Seo… - researchgate.net
ABSTRACT Indoleamine 2, 3-dioxygenase 1 (IDO1) is an enzyme participating in tryptophan
metabolism that has been implicated in numerous cancers. In the present study, a series of …

Design, Synthesis and Evaluation the Bioactivites of Novel Quinazoline Derivatives as Immune Checkpoint Inhibitors

TTL Vo, VH Hoang, PTP Dung, TK Nguyen… - Available at SSRN … - papers.ssrn.com
Abstract Indoleamine 2, 3-dioxygenase (IDO1) has emerged as a critical immune checkpoint
with profound implications in numerous types of cancer. Dysregulation of IDO1 has …

Tổng hợp và đánh giá tác dụng ức chế indoleamin 2,3-dioxygenase 1 của một số dẫn chất acetamid thơm mang khung 6-amino-1H-indazol

XH Ngô, VH Dương, TH Nguyễn, PT Trần - Tạp chí Nghiên cứu Dược và …, 2022 - jprdi.vn
Tóm tắt Five novel aromatic acetamide bearing 6-amino-1H-indazol scaffold compounds
(IVa-e) were designed and synthesized through foursteps by well-known reactions. These …